Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1B | P00325 | 3/20 | 0.53 |
| ▸ | ADH1C | P00326 | 3/20 | 0.53 |
| ▸ | ADH1A | P07327 | 3/20 | 0.53 |
| ▸ | ADH7 | P40394 | 3/20 | 0.53 |
| ▸ | ADH4 | P08319 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.39 |
| ▸ | GAPDH | P04406 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7677961 | 0.84 | ADH1B (0.46) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL3361816 | 0.82 | LMNA (0.34) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL5387915 | 0.80 | ADH1B (0.57) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL7678770 | 0.79 | ADH1B (0.42) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL11225078 | 0.79 | ADH1B (0.48) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL21887554 | 0.79 | ADH1B (0.48) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL4795083 | 0.79 | ADH1B (0.48) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL17808429 | 0.79 | ADH1B (0.48) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL19185677 | 0.79 | ADH1B (0.48) | ADH1BADH1CADH1AADH7ADH4 | |
| SCHEMBL2496264 | 0.78 | TSHR (0.47) | ADH1BADH1CADH1AADH7ADH4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100041622-A1 | Compositions containing aminoalkanes and aminoalkane derivatives | VIRUN, INC. | 2010-02-18 | — | — | US | disclosed |
| WO-2010019255-A1 | COMPOSITIONS CONTAINING AMINOALKANES AND AMINOALKANE DERIVATIVES | VIRUN, INC. (US) | 2010-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041622-A1 | Compositions containing aminoalkanes and aminoalkane derivatives | TAAR5, PDE3A, PDE2A | ADH1B 1211/4885ADH1C 285/4885ADH1A 160/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.